« Back
Home /
Osimertinib (dimesylate)

Osimertinib (dimesylate)

Manufacturer	MedChem Express
Category	Oncology Neuroscience Neural Signaling Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer Bladder Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	500 mg
Item no.	HY-79077-500mg
Targets	EGFR
CASRN	2070014-82-1
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Osimertinib dimesylate (AZD-9291 dimesylate) is an irreversible and mutant selective EGFR inhibitor with IC50s of 12 and 1 nM against EGFRL858R and EGFRL858R/T790M, respectively.
StorageTemperature	4°C (Powder, sealed storage, away from moisture)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	691.82
Clinical_Information	Launched
Manufacturers Research_Area	Cancer
Solubility	DMSO : 2.63 mg/mL (ultrasonic)\|H2O : 100 mg/mL (ultrasonic)
Isoform	EGFR/ErbB1/HER1
Pathway	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-79077-500mg-safety-datasheet.pdf